Immature Plateletes in the Etiopathology of Deep Venous Thrombosis (iPLATELET)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02361294|
Recruitment Status : Unknown
Verified February 2015 by Technische Universität München.
Recruitment status was: Recruiting
First Posted : February 11, 2015
Last Update Posted : February 11, 2015
|Condition or disease||Intervention/treatment|
|Immature Platelets Deep Venous Thrombosis||Other: Blood samples|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Prospective Study to Generate Hypotheses About the Role of Platelets and Immature Platelets in the Pathogenesis of Idiopathic Venous Thromboses and Pulmonary Embolisms|
|Study Start Date :||December 2014|
|Estimated Primary Completion Date :||December 2015|
|Estimated Study Completion Date :||March 2016|
Patients with a newly diagnosed deep venous thrombosis and/or pulmonary embolism. The thrombembolism is idiopathic or caused by immobilisation. Three blood samples are taken during the study period. A thrombophilia screening is carried out.
|Other: Blood samples|
Patients that present with a suspicion of deep venous thrombosis which is excluded by duplex sonography. One to two blood samples are taken during the study period.
|Other: Blood samples|
- Significantly increased proportion of immature platelets in patients with deep venous thrombosis and/or pulmonary embolism compared to the control. [ Time Frame: at time of diagnosis ]
- Significantly higher values of platelet function in patients with deep venous thrombosis and/or pulmonary embolism compared to the control. [ Time Frame: at time of diagnosis ]
- A persistently increased proportion of immature platelets in patients with deep venous thrombosis and/or pulmonary embolism compared to the controls three months after diagnosis. [ Time Frame: 3 months after diagnosis ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02361294
|Contact: Tareq Ibrahim, MD||0049 89 4140 firstname.lastname@example.org|
|Contact: Nicolas Langwieser, MD||0049 89 4140 email@example.com|
|Klinikum rechts der Isar, Technische Universität München||Recruiting|
|Contact: Tareq Ibrahim, MD 0049 89 4140 2350 firstname.lastname@example.org|
|Principal Investigator:||Tareq Ibrahim, MD||Senior consultant|